Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: Experience in 1000 consecutive cases

European Heart Journal

Volumn 25, Issue 14, 2004, Pages 1230-1236

  Wahl, Andreas ^a,b   Paetsch, Ingo ^a   Gollesch, Albrecht ^a   Roethemeyer, Stefan ^a,c   Foell, Daniela ^a   Gebker, Rolf ^a   Langreck, Holger ^a   Klein, Christoph ^a   Fleck, Eckart ^a   Nagel, Eike ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c Heart Center Osnabrueck Bad   (Germany)

Author keywords

Coronary artery disease; Feasibility; Ischaemia; Magnetic resonance imaging; Safety; Stress testing

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG SAFETY; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SIDE EFFECT; THORAX PAIN; URINARY URGENCY;

ADULT; AGED; AGED, 80 AND OVER; ATROPINE; CARDIOTONIC AGENTS; DOBUTAMINE; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 3042833235     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.11.018     Document Type: Article

References (21)

1. Nagel E., Lehmkuhl H.B., Bocksch W., et al. Noninvasive diagnosis of ischaemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 99:1999;763-770
2. Hundley W.G., Hamilton C.A., Thomas M.S., et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischaemia in patients not well suited for second harmonic stress echocardiography. Circulation. 100:1999;1697-1702
3. Thiele H., Nagel E., Paetsch I., et al. Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents. J. Magn. Reson. Imaging. 14:2001;362-367
4. Nagel E., Lorenz C., Baer F., et al. Stress cardiovascular magnetic resonance: consensus panel report. J. Cardiovasc. Magn. Reson. 3:2001;267-281
5. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J. Am. Soc. Echocardiogr. 2:1989;358-367
6. Poldermans D., Fioretti P.M., Boersma E., et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am. J. Cardiol. 73:1994;456-459
7. Picano E., Mathias W., Pingitore A., et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo dobutamine international cooperative study group. Lancet. 344:1994;1190-1192
8. Geleijnse M.L., Fioretti P.M., Roelandt J.R. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J. Am. Coll. Cardiol. 30:1997;595-606
9. Secknus M.A., Marwick T.H. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3, 011 studies over 5 years. J. Am. Coll. Cardiol. 29:1997;1234-1240
10. Mathias W., Arruda A., Santos F.C., et al. Safety of dobutamine-atropine stress echocardiography: A prospective experience of 4, 033 consecutive studies. J. Am. Soc. Echocardiogr. 12:1999;785-791
11. Takeuchi M., Miura Y., Sonoda S., et al. Comparison of three different protocols for dobutamine stress echocardiography: Does the addition of atropine increase complications, and does it improve diagnostic accuracy? Echocardiography. 16:1999;347-355
12. Lattanzi F., Picano E., Adamo E., et al. Dobutamine stress echocardiography: safety in diagnosing coronary artery disease. Drug Saf. 22:2000;251-262
13. Cornel J.H., Balk A.H., Boersma E., et al. Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischaemic left ventricular dysfunction. J. Am. Soc. Echocardiogr. 9:1996;27-32
14. Gibbons R.J., Balady G.J., Timothy Bricker J., et al. ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 106:2002;1883-1892
15. Pina I.L., Balady G.J., Hanson P., et al. Guidelines for clinical exercise testing laboratories. A statement for healthcare professionals from the committee on exercise and cardiac rehabilitation, american heart association. Circulation. 91:1995;912-921
16. Rodgers G.P., Ayanian J.Z., Balady G., et al. American college of cardiology/american heart association clinical competence statement on stress testing. A report of the american college of cardiology/american heart association/american college of physicians-american society of internal medicine task force on clinical competence. Circulation. 102:2000;1726-1738
17. Shellock F.G., Crues J.V. MR safety and the american college of radiology white paper. AJR Am. J. Roentgenol. 178:2002;1349-1352
18. Kanal E., Borgstede J.P., Barkovich A.J., et al. American college of radiology white paper on MR safety. AJR Am. J. Roentgenol. 178:2002;1335-1347
19. Hamilton C.A., Link K.M., Salido T.B., et al. Is imaging at intermediate doses necessary during dobutamine stress magnetic resonance imaging? J. Cardiovasc. Magn. Reson. 3:2001;297-302
20. Sutherland G.R., Kukulski T., Kvitting J.E., et al. Quantitation of left-ventricular asynergy by cardiac ultrasound. Am. J. Cardiol. 86:2000;4G-9G
21. Francis J.M., Pennell D.J. Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation. J. Cardiovasc. Magn. Reson. 2:2000;139-141